Biphenyl

Biphenyl

SCHEMBL1698235

C.N.N.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.82
MAPK1 P28482 2/20 0.53
TAAR1 Q96RJ0 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
HSD17B10 Q99714 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
NOTUM Q6P988 1/20 0.53
MMP3 P08254 1/20 0.53
BCL2L1 Q07817 1/20 0.53
ATM Q13315 1/20 0.47
SLC22A2 O15244 1/20 0.47
SLC22A1 O15245 1/20 0.47
SLC22A3 O75751 1/20 0.47
SLC6A4 P31645 1/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
MAOA P21397 1/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL27333120 1.00 ALDH1A1 (0.82) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL29210065 0.95 ALDH1A1 (0.90) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL29078567 0.95 ALDH1A1 (0.90) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL4603524 0.95 ALDH1A1 (0.90) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL10791683 0.95 ALDH1A1 (0.90) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL43102 0.95 ALDH1A1 (0.90) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL164459 0.95 ALDH1A1 (0.90) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL688885 0.95 ALDH1A1 (0.90) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL302887 0.95 ALDH1A1 (0.90) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL10806270 0.91 ALDH1A1 (0.82) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 561 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122011732-A Halogen-free epoxy resin composition, aerogel packaging film, preparation method and application 皇冠新材料科技股份有限公司 2026-05-12 CN claimed
EP-3947522-B1 PROCESS FOR PROVIDING A HOMOGENEOUS POLYETHER POLYOL COMPOSITION, REACTION MIXTURE COMPRISING A COMPOSITION OBTAINED BY THE PROCESS, AND POLYURETHANE PRODUCTS OBTAINED FROM THE REACTION MIXTURE HUNTSMAN INT LLC (US) 2025-10-15 EP claimed
CN-116217439-B Circulation solvent for preparing MDI by phosgenation and purification method thereof 万华化学集团股份有限公司 2025-05-13 CN claimed
CN-118622990-B Composite layered sealing method for preventing low-viscosity glue solution from being immersed into actuating mechanism 北京机械设备研究所 2025-05-02 CN claimed
CN-119736002-A Dirt-sticking-preventing powder coating and preparation method and application thereof 中山虹丽美新材料科技有限公司 2025-04-01 CN claimed
CN-119639418-A High-elasticity high-flexibility structural adhesive and preparation method thereof 佛山市顺德区威固星硅胶有限公司 2025-03-18 CN claimed
US-12187839-B2 Polyether polyol HUNTSMAN INTERNATIONAL LLC 2025-01-07 US claimed
CN-119081609-A Recoverable mussel-like bio-based epoxy resin adhesive and preparation method thereof 西南大学 2024-12-06 CN claimed
CN-118955834-A Epoxy vegetable oil glass polymer material and preparation method thereof 西南大学 2024-11-15 CN claimed
CN-115806508-B Diphenylmethane diisocyanate with low 2,2' -MDI content and preparation method thereof 万华化学(宁波)有限公司 2024-10-18 CN claimed
CN-1505605-A Process for the synthesis of mixtures of methane diphenyl diamine and its higher homologues with controlled isomer distribution 2004-06-16 CN claimed
US-20040029971-A1 Process for the synthesis of mixtures of methane diphenyl diamine and its higher homologues with a controlled isomer distribution ENICHEM S.P.A. (IT) 2004-02-12 US claimed
EP-1381589-A1 PROCESS FOR THE SYNTHESIS OF MIXTURES OF METHANE DIPHENYL DIAMINE AND ITS HIGHER HOMOLOGUES WITH A CONTROLLED ISOMER DISTRIBUTION ENI S.p.A. (IT) 2004-01-21 EP claimed
EP-1355874-A1 PROCESS FOR THE SYNTHESIS OF MIXTURES OF METHANE DIPHENYL DIAMINE AND ITS HIGHER HOMOLOGUES WITH A CONTROLLED ISOMER DISTRIBUTION DOW GLOBAL TECHNOLOGIES INC. (US) 2003-10-29 EP claimed
WO-2002088067-A1 PROCESS FOR THE SYNTHESIS OF MIXTURES OF METHANE DIPHENYL DIAMINE AND ITS HIGHER HOMOLOGUES WITH A CONTROLLED ISOMER DISTRIBUTION DOW GLOBAL TECHNOLOGIES INC. (US) 2002-11-07 WO claimed
WO-2002020458-A1 PROCESS FOR THE SYNTHESIS OF MIXTURES OF METHANE DIPHENYL DIAMINE AND ITS HIGHER HOMOLOGUES WITH A CONTROLLED ISOMER DISTRIBUTION DOW GLOBAL TECHNOLOGIES INC. (US) 2002-03-14 WO claimed
CN-1038056-C In situ cool mixing unheated materials and filling into expansion joint of solidifying bridge XI AN HIGHWAY COLLEGE (CN) 1998-04-15 CN claimed
EP-0356814-B1 Method for the preparation of polyether polyols based on aromatic di- and/or polyamines and their use in polyurethane and polyisocyanate synthetic materials BAYER AG (DE) 1994-11-17 EP claimed
US-5334673-A From a thermosetting composition cured with a slow-reacting polyamine ACUSHNET CO. (US) 1994-08-02 US claimed
EP-0022497-B1 PROCESS FOR THE PREPARATION OF ELASTIC, OPTIONALLY CELLULAR POLYURETHANE UREAS BAYER AG (DE) 1983-05-11 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040029971-A1 Process for the synthesis of mixtures of methane diphenyl diamine and its higher homologues with a controlled isomer distribution AOC1, DDT, DDC ALDH1A1 1605/4885MAPK1 4414/4885TAAR1 556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.